You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • Reference number: TA307
  • Published:  25 March 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Colorectal cancer (metastatic) - aflibercept: appeal

  • Colorectal cancer (metastatic) - aflibercept: appeal decision

  • Colorectal cancer (metastatic) - aflibercept: appeal announcement

  • Colorectal cancer (metastatic) - aflibercept: register to attend the appeal

  • Colorectal cancer (metastatic) - aflibercept: notice of appeal


This page was last updated: 21 March 2014

Back to top